Filgrastim for the treatment of leukemia relapse after bone marrow transplantation

Bone Marrow Transplantation

Volumn 18, Issue 4, 1996, Pages 817-819

  Carral, A ^a   Sanz, G F ^a   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bone marrow transplantation; Filgrastim; G CSF; Leukemic relapse

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE PAIN; CASE REPORT; DRUG USE; FEMALE; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; PARESTHESIA; PRIORITY JOURNAL; RELAPSE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; BONE MARROW; BONE MARROW TRANSPLANTATION; FEMALE; FILGRASTIM; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029806778     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kumar L. Management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710-1717.
2. Mrsic M, Horowitz MM, Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
3. Shing MMK, Vowels M. Role of second bone marrow transplants. Bone Marrow Transplant 1993; 12: 21-25.
4. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482 (letter).
5. Martinez J, Picon I, Carral A et al. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient wtih acute myeloid leukemia in relapse. Bone Marrow Transplant 1995; 15: 149-151.
6. Higano CS, Brixley M, Bryant EH et al. Durable complete remission of acute non-lymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. Transplantation 1990; 50: 175-177.
7. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2460-2465.
8. Shaffer L, Giralt S, Champlin R, Char KW. Treatment of leukemia relapse after bone marrow transplantation with interferon-alfa and interleukin 2. Bone Marrow Transplant 1995; 15: 317-319.
9. Giralt S, Escudier S, Kantarjian H et al. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. New Engl J Med 1993; 329: 757-761.
10. Giralt S, Champlin R. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
11. Vose JM, Armitage JO. Clinical applications of hematopoietic growth factors. J Clin Oncol 1995; 13: 1023-1035.
12. Ohno R, Tomonaga M, Kobayashi T et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New Engl J Med 1990; 328: 871-877.
13. Frampton JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994; 48: 731-760.
14. Giralt S, Hester J, Talpaz M et al. Cytokine therapy for patients relapsing after allogeneic bone marrow transplantation. J Cell Biochem 1994; 18B Suppl: 88a (Abstr.).